The Abbasov Group works at the interface of chemistry, biology, and medicine to develop chemical and technological strategies that modulate protein function...

Dr. Awasthi's multidisciplinary research integrates nuclear/molecular imaging (PET/SPECT radiopharmaceuticals) with drug delivery systems (liposomes, nanoparticles) and pharmacotherapy to study diagnostic and treatment mechanisms in cardiovascular injury, pulmonary fibrosis, metabolic diseases, hemorrhagic shock, and cancer.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Phasellus at urna id nisi suscipit fringilla quis sit amet leo. Donec lobortis quis lacus eget consectetur. 

The Gallucci Lab investigates the positive and negative roles that inflammation plays during injury and subsequent repair of skin, with the ultimate goal of augmenting wound healing through the manipulation of inflammatory pathways.etur. 

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Phasellus at urna id nisi suscipit fringilla quis sit amet leo. Donec lobortis quis lacus eget consectetur. 

The Ihnat Lab studies how anticancer drugs differ in their ability to induce immunogenic cell death in triple-negative breast cancer, with the goal of identifying treatment strategies that improve antitumor immune responses and strengthen immunotherapy.

We are advancing a transformative exosome-based therapeutic platform that combines natural targeting capabilities with innovative drug delivery strategies...

The Standifer Lab works to improve treatments for people affected by traumatic brain injury (TBI), post traumatic stress disorder (PTSD), and chronic pain. Our goal is to better understand how the brain responds to physical and emotional trauma so we can help develop new and more effective therapies.

The Agrahari Lab integrates a multidisciplinary approach to design innovative nanoformulations and biomaterial-based therapeutics that enable minimally invasive, localized, and targeted drug delivery for ocular and hearing disorders.

Research in my laboratory focuses on developing innovative immunotherapeutic strategies that harness the body's natural host defense mechanisms. Our work centers on investigating underlying mechanisms...

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Phasellus at urna id nisi suscipit fringilla quis sit amet leo. Donec lobortis quis lacus eget consectetur. 

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Phasellus at urna id nisi suscipit fringilla quis sit amet leo. Donec lobortis quis lacus eget consectetur. 

The primary focus of our lab is to develop a multi-targeted peptide drug that halts the decline in cognitive function associated with Alzheimer’s disease (AD). We focus on in vitro and in vivo preclinical testing of peptide candidates. Our goal is...

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Phasellus at urna id nisi suscipit fringilla quis sit amet leo. Donec lobortis quis lacus eget consectetur. 

The Pereira lab develops first-in-class peptide therapeutics inspired by the neutrophil protein CAP37 to address multidrug-resistant Gram-negative infections. We focus on high-impact settings—especially ocular and...

The Yue research program focuses on studying novel mechanisms involved in the regulation of drug transporter function. The long-term goal of the Yue laboratory is to establish a mechanistic model to predict transporter-mediated drug-drug interactions (DDIs) and inter-individual variability in drug response.